FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, and in particular to a method for prolonging the release of albumin from the shadows of red blood cells. Method of prolonging the release of albumin from the shadows of red blood cells, including the use as containers of shadows of red blood cells, obtained by the hypoosmotic shock of native red blood cells and incubating them in a solution of biologically active substances, followed by "closing" the shadows of red blood cells in an isotonic medium, in this case, "closing" the shadows of erythrocytes is carried out by adding to them a solution of glutaraldehyde, followed by laundering of the shadows from the glutaraldehyde outside the shadows.
EFFECT: above method allows for the prolonged release of albumin from the shadow of red blood cells.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DELIVERING BIOLOGICALLY ACTIVE SUBSTANCES TO SCAFFOLD | 2018 |
|
RU2665155C1 |
METHOD FOR MICROSCOPIC ASSESSMENT OF CYTOTOXICITY OF COMPONENTS OF SCAFFOLD MATERIALS | 2017 |
|
RU2653476C1 |
ACTIVATED LEUKOCYTE COMPOSITION | 2010 |
|
RU2548741C2 |
ADHESIVE BIOACTIVE MATRIX FOR WORKING WITH CELL CULTURES AND METHOD FOR USE THEREOF | 2023 |
|
RU2817370C1 |
METHOD FOR INCLUDING BIOLOGICALLY ACTIVE COMPONENTS IN ERYTHROCYTES BY METHOD OF FLOW HYPOOSMOTIC DIALYSIS | 2021 |
|
RU2791817C1 |
METHOD OF DETERMINING THE IMMUNOLOGIC STATE OF ORGANISM | 0 |
|
SU1090409A1 |
AGENT FOR TRANSFERRING NUCLEIC ACIDS OR THEIR DERIVATIVES IN HUMAN CELLS | 1992 |
|
RU2113485C1 |
METHOD FOR DETECTING CYTOTOXIC EFFECT AND GROWTH-STIMULATING ACTIVITY OF SUBSTANCES FOR PRECLINICAL TRIALS | 2002 |
|
RU2226275C2 |
METHOD FOR PREPARING BIOLOGICALLY ACTIVE COMPLEX AND BIOLOGICALLY ACTIVE PROTEIN-POLYPEPTIDE COMPLEX | 2010 |
|
RU2428196C1 |
BIOCOMPATIBLE BIODEGRADABLE SCAFFOLD BASED ON POLYMER COMPOSITE CONTAINING HYDROXYAPATITE NANOPARTICLES | 2019 |
|
RU2756551C2 |
Authors
Dates
2019-03-28—Published
2018-01-26—Filed